Page last updated: 2024-08-23

simvastatin and African Lymphoma

simvastatin has been researched along with African Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berges, C; Daniel, V; Fuchs, D; Naujokat, C; Opelz, G	1

Other Studies

1 other study(ies) available for simvastatin and African Lymphoma

Article	Year
HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway. Biochemical and biophysical research communications, 2008, Sep-19, Volume: 374, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Burkitt Lymphoma; Cell Division; Cell Line; Cell Membrane; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; G2 Phase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myeloid Cell Leukemia Sequence 1 Protein; Polyisoprenyl Phosphates; Proto-Oncogene Proteins c-bcl-2; Pyrazines; rhoA GTP-Binding Protein; Simvastatin	2008

Article

Year

HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.

Biochemical and biophysical research communications, 2008, Sep-19, Volume: 374, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Burkitt Lymphoma; Cell Division; Cell Line; Cell Membrane; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; G2 Phase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myeloid Cell Leukemia Sequence 1 Protein; Polyisoprenyl Phosphates; Proto-Oncogene Proteins c-bcl-2; Pyrazines; rhoA GTP-Binding Protein; Simvastatin

2008